Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP).
Carbohydrate response element binding protein (ChREBP) is a Mondo family transcription factor that activates a number of glycolytic and lipogenic genes in response to glucose stimulation. We have previously reported that high glucose can activate the transcriptional activity of ChREBP independent of the protein phosphatase 2A (PP2A)-mediated increase in nuclear entry and DNA binding. Here, we found that formation of glucose-6-phosphate (G-6-P) is essential for glucose activation of ChREBP. The glucose response of GAL4-ChREBP is attenuated by D-mannoheptulose, a potent hexokinase inhibitor, as well as over-expression of glucose-6-phosphatase (G6Pase); kinetics of activation of GAL4-ChREBP can be modified by exogenously expressed GCK. Further metabolism of G-6-P through the two major glucose metabolic pathways, glycolysis and pentose-phosphate pathway, is not required for activation of ChREBP; over-expression of glucose-6-phosphate dehydrogenase (G6PD) diminishes, whereas RNAi knockdown of the enzyme enhances, the glucose response of GAL4-ChREBP, respectively. Moreover, the glucose analogue 2-deoxyglucose (2-DG), which is phosphorylated by hexokinase, but not further metabolized, effectively upregulates the transcription activity of ChREBP. In addition, over-expression of phosphofructokinase (PFK) 1 and 2, synergistically diminishes the glucose response of GAL4-ChREBP. These multiple lines of evidence support the conclusion that G-6-P mediates the activation of ChREBP.
Li
Ming V
MV
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Chen
Weiqin
W
Harmancey
Romain N
RN
Nuotio-Antar
Alli M
AM
Imamura
Minako
M
Saha
Pradip
P
Taegtmeyer
Heinrich
H
Chan
Lawrence
L
D000818:Animals; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D002460:Cell Line; D003847:Deoxyglucose / Q000494:pharmacology; D019298:Glucose-6-Phosphate / Q000378:metabolism* / Q000494:pharmacology; D006019:Glycolysis; D006801:Humans; D051379:Mice; D009687:Nuclear Proteins / Q000096:biosynthesis*; D010732:Phosphofructokinase-1 / Q000378:metabolism; D025481:Phosphofructokinase-2 / Q000378:metabolism; D014157:Transcription Factors / Q000096:biosynthesis*
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; C506001:Mlxipl protein, mouse; D009687:Nuclear Proteins; D014157:Transcription Factors; D019298:Glucose-6-Phosphate; D003847:Deoxyglucose; D025481:Phosphofructokinase-2; D010732:Phosphofructokinase-1
Annu Rev Nutr. 1997;17:325-52
9240931
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9116-21
11470916
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13710-5
11698644
Annu Rev Nutr. 1987;7:157-85
3300731
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E358-64
16705063
Nat Genet. 2003 Mar;33(3):401-6
12590264
Annu Rev Nutr. 1997;17:405-33
9240934
Mol Endocrinol. 2008 Jul;22(7):1658-72
18436566
Biochem Mol Med. 1997 Aug;61(2):168-77
9259982
J Biol Chem. 1992 Oct 15;267(29):20543-6
1356982
Physiol Rev. 1995 Jan;75(1):47-76
7831398
J Biol Chem. 1993 Nov 15;268(32):23881-90
8226928
J Biol Chem. 1991 May 15;266(14):8679-82
2026584
Biochem J. 1975 Dec;152(3):571-6
776171
Nat Genet. 2008 Feb;40(2):149-51
18193046
Diabetes. 2006 May;55(5):1179-89
16644671
Cell. 1995 May 19;81(4):541-50
7758108
Diabetes. 2000 Mar;49(3):424-30
10868964
J Lipid Res. 2006 Nov;47(11):2482-91
16891625
Biochem Biophys Res Commun. 2006 Feb 10;340(2):449-56
16375857
Nucleic Acids Res. 1992 Apr 25;20(8):1871-7
1315961
J Biol Chem. 2008 Aug 29;283(35):24029-38
18591247
Diabetes. 2006 Aug;55(8):2159-70
16873678
Endocrinology. 1992 Jan;130(1):167-78
1370150
Endocr Rev. 1997 Aug;18(4):520-40
9267763
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5107-12
12684532